GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Egyptian International Pharmaceutical Investments (CAI:PHAR) » Definitions » Tax Provision

Egyptian International Pharmaceutical Investments (CAI:PHAR) Tax Provision : E£-398 Mil (TTM As of Sep. 2024)


View and export this data going back to 1995. Start your Free Trial

What is Egyptian International Pharmaceutical Investments Tax Provision?

Egyptian International Pharmaceutical Investments's tax provision for the three months ended in Sep. 2024 was E£-103 Mil. Its tax provision for the trailing twelve months (TTM) ended in Sep. 2024 was E£-398 Mil.


Egyptian International Pharmaceutical Investments Tax Provision Historical Data

The historical data trend for Egyptian International Pharmaceutical Investments's Tax Provision can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Egyptian International Pharmaceutical Investments Tax Provision Chart

Egyptian International Pharmaceutical Investments Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Tax Provision
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - -165.89 -160.98 -259.95

Egyptian International Pharmaceutical Investments Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Tax Provision Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -59.60 -50.80 -83.33 -160.21 -103.25

Egyptian International Pharmaceutical Investments Tax Provision Calculation

Tax to be paid.

Tax Provision for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was E£-398 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Egyptian International Pharmaceutical Investments Business Description

Traded in Other Exchanges
N/A
Address
1st Industrial Zone B1, P.O. Box 149 10th, 10th of Ramadan, EGY
Egyptian International Pharmaceutical Investments is an Egypt based company pharmaceutical generic drugs. It holds license agreements with a group of pharmaceutical companies to produce their products locally and replace the imported ones. The company produces dosage forms, Spansule capsules, Antibiotics, Lyophilized Products. It exports its products to African, Asian and East European and Latin American Countries.

Egyptian International Pharmaceutical Investments Headlines

From GuruFocus

Q4 2021 Pharming Group NV Earnings Call Transcript

By GuruFocus Research 02-08-2024

Pharming announces sale of priority review voucher

By PRNewswire PRNewswire 06-01-2023

Q4 2023 Pharming Group NV Earnings Call Transcript

By GuruFocus Research 03-15-2024

Q2 2022 Pharming Group NV Earnings Call Transcript

By GuruFocus Research 02-08-2024

Q4 2020 Pharming Group NV Earnings Call Transcript

By GuruFocus Research 02-08-2024

Q1 2023 Pharming Group NV Earnings Call Transcript

By GuruFocus Research 02-08-2024

Pharming Group NV Annual Shareholders Meeting Transcript

By GuruFocus Research 02-08-2024

Q3 2023 Pharming Group NV Earnings Call Transcript

By GuruFocus Research 02-08-2024

Q2 2023 Pharming Group NV Earnings Call Transcript

By GuruFocus Research 02-08-2024